Abstract
The kinetics of cholic acid (C) and chenodeoxycholic acid (CD) were studied in six patients with portal liver cirrhosis. The studies were conducted both before and after 5–6 weeks of treatment with cholestyramine (12 g/day). In keeping with previous observations, the pool size and formation of C showed subnormal values during the pretreatment period, while the production of CD was within normal limits. The pool sizes of C and CD did not change upon treatment with cholestyramine, but the mean total bile acid formation increased by a factor of about 2.5. The ratio between the amounts of C and CD synthesized remained essentially unchanged. Considering the therapeutic response previously observed in normal subjects and in patients with hyper-β-lipoproteinemia, the present results suggest a selective impairment of the biosynthesis of C in patients with portal liver cirrhosis. It is suggested that the primary defect may reside in the 12α-hydroxylase enzyme system.
Similar content being viewed by others
References
Vlahcevic ZR, Buhac I, Farrar JT, Bell CC, Jr, Swell L: Bile acid metabolism in patients with cirrhosis. I. Kinetic aspects of cholic acid metabolism. Gastroenterology 60:491–498, 1971
Vlahcevic ZR, Juttijudata P, Bell CC, Jr, Swell L: Bile acid metabolism in patients with cirrhosis. II. Cholic and chenodeoxycholic acid metabolism. Gastroenterology 62:1174–1181, 1972
McCormick, WC, III, Bell CC, Jr, Swell L, Vlahcevic ZR: Cholic acid synthesis as an index of the severity of liver disease in man. Gut 14:895–902, 1973
Einarsson K, Hellström K, Scherstén T: The formation of bile acids in patients with portal liver cirrhosis. Scand J Gastroenterol 10:299–304, 1975
Einarsson K, Hellström K, Kallner M: Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia. J Clin Invest 54:1301–1311, 1974
Einarsson K, Hellström K, Kaller M: The effect of cholestyramine on the elimination of cholesterol as bile acids in patients with hyperlipoproteinemia type II and IV. Eur J Clin Invest 4:405–410, 1974
Lindstedt S: Turnover of cholic acid in man. Acta Physiol Scand 40:1–9, 1957
Snedecor GW, Cochran WG: Statistical Methods, 6th ed. Iowa State University Press, Ames, 1974
Miettinen T: Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease. Gut 13:682–689, 1972
Grundy SM, Ahrens EH, Jr, Salen G: Interruption of the enterohepatic circulation of bile acids in man: Comparative effects of cholestyramine and ileal exclusion on cholesterol metabolism. J Lab Clin Med 78:94–121, 1971
Garbutt JT, Kenney TJ: Effect of cholestyramine on bile acid metabolism in normal man. J Clin Invest 51:2781–2789, 1972
Danielsson H, Sjövall J: Bile acid metabolism. Annu Rev Biochem 44:233–253, 1975
Mitropoulos KA, Myant NB, Gibbons GF, Balasubramaniam S, Reeves BEA: Cholesterol precursor pools for the synthesis of cholic and chenodeoxycholic acids in rats. J Biol Chem 249:6052–6056, 1974
Andersén E: Effect of cholestyramine on bile acid kinetics in normolipidemic subjects. To be published.
Author information
Authors and Affiliations
Additional information
Supported by grants from Karolinska Institutets Forsknings-fonder and from the Loo and Hans Osterman Foundation.
Rights and permissions
About this article
Cite this article
Angelin, B., Einarsson, K. & Hellstrom, K. Effect of cholestyramine on bile acid kinetics in patients with portal cirrhosis of the liver. Digest Dis Sci 23, 1115–1120 (1978). https://doi.org/10.1007/BF01072887
Issue Date:
DOI: https://doi.org/10.1007/BF01072887